Report ID: ATR-2025-Q4 · Data as of: December 31, 2025 · Published: January 1, 2026 · Issue: Q4 2025 (annual review)
Editor's note (July 28, 2026). This is a retrospective issue, backfilled to complete the series archive. It was reconstructed from the dataset's documented changes log and contemporaneous primary sources, and its analysis is limited to information documented as of December 31, 2025. The first issue of the series produced in real time is ATR-2026-Q3.
Methodology note. This report follows the source-confidence and aggregation rules documented on the site's Methodology page. Every figure carries an inline tag: (a) filed court document (annual report, quarterly filing, or payment-percentage notice); (b) secondary source citing a primary document; (c) estimate or inference. Class-(c) figures are excluded from point sums and appear only in ranges, per the methodology. All underlying data: client/src/data/trust-figures.json in this repository. No untagged figures are used. Nothing here is legal or financial advice.
How to cite: Asbestos Trust Tracker, State of the Asbestos Trust System — 2025 Year in Review (ATR-2025-Q4), data as of December 31, 2025, asbestostrusts.org.
Comparability note. This is the series' first annual review; there is no prior annual issue to diff against. The reporting window is calendar year 2025; movement within the window is reconstructed from the dataset's documented changes log.
Entering and exiting 2025, the system's documented floor stood at approximately $17.0B. Its composition at year-end: exactly $13,076,231,337 across 32 trusts carried on credible secondary compilations of trust annual reports — 28 at FY2022 vintages and 4 at FY2021 (b) — plus approximately $4.0B across the nine trusts that file public annual or quarterly reports, carried at their FY2024 filed values (a, as a class; the dataset preserves exact filed arithmetic only from the FY2025 cycle forward, so the year-end floor is printed as ≈$17.0B rather than an exact sum. We flag that gap rather than reconstruct around it; this is the only issue in the series without an exact floor).
The floor is not a census, and it is deliberately conservative. Roughly 19 of the ~60 active trusts publish no retrievable figure at all, and the 32 secondary-carried figures are dated — trusts deplete over time, so dated figures overstate some balances while the uncounted ~19 trusts push the other way. The estimated high end of the working range remains $22.5B (c), anchored on documented waypoints: the Institute for Legal Reform's 2018 Dubious Distribution study found ~$25B in trust assets plus ~$2B in deferred funding obligations at year-end 2016 (b); more than $1.5B of those deferred obligations have since funded, including Honeywell's $1.325B buyout into NARCO in January 2023 (a) and the Western Asbestos deferred contribution completed in 2024 (b); against that, net depletion has run at roughly $0.5B per year since 2016 (c).
What moved in 2025 was not the floor's size but its story. No trust migrated onto filed-document footing during the year — the FY2024 free filings refreshed values without changing tiers — so the aggregate narrative of 2025 is carried almost entirely by events: one closure (Section D), four payment-percentage cuts and the system's first documented deferral period (Section B), and an end-of-year administration transition at the system's largest-percentage trust.
For the record, the citation correction this series exists to enforce: the ubiquitous "$30 billion in asbestos trusts" traces to GAO-11-819's finding of ~$36.8B in total capitalization — initial funding plus investment returns — across 60 trusts established by 2011 (a). That was never a current balance; the same report documented $17.5B already paid on 3.3 million claims through 2010 (a).
2025 was the busiest year for downward adjustments since the current cycle began. Four documented cuts landed:
The deferral. Celotex entered a Deferral Period on January 1, 2025, holding its payment percentage at 7% (a) — the first deferral documented in the dataset. Deferral is what trusts do when the alternative is cutting into nominal-recovery territory; it belongs in the same ledger as cuts, one row below.
Held through 2025 (documented): NARCO at 100% (a), DII Industries at 60% (a), Thorpe Insulation at 58.6% (a), Western at 51.1% (a), Plant at 20% (a), Manville at 5.1% (a). Pittsburgh Corning spent the entire year at its reconsidered 19%, the November 2024 cut (from 24.5%) still pending TAC/FCR consent with a true-up rider if not adopted (a). H.K. Porter held at 3.0% and resumed making new offers by January 31, 2025, after a December 2024 court order confirmed the trustee's authority to amend §4.1 of its claims resolution procedures (a) — a year of procedural limbo resolved without a percentage change.
Outside the tracked floor: Shook & Fletcher raised its percentage 50% → 58% in May 2025 (b). That trust carries no retrievable asset figure and sits outside the 41-trust floor, but the raise is worth printing for two reasons: it is a documented counterexample to any claim that percentages only fall, and it is a reminder that the ~19 untracked trusts move in both directions unobserved.
Trailing record since January 2023: six documented cuts (Celotex, June 2023; Pittsburgh Corning, November 2024; the four 2025 cuts above), zero raises within the tracked set. The most recent documented increase in the set remains Manville's 4.3% → 5.1% raise of February 2021, with its ~$5.6M retroactive true-up (a). Across the 21 published percentages in and around the floor, the median sits at 15.0% (derived from (a)/(b) figures).
Where documents exist, the outflow is substantial and persistent. The documented eight-trust subset — Pittsburgh Corning, W.R. Grace, Manville, GAF, Western, Plant, API, and Combustion Engineering — paid ~$591.9M in claims in 2022 and ~$561.2M in 2024 (a). Cumulatively, the hard documented floor remains the GAO's $17.5B paid on 3.3M claims, 1988–2010 (a); the working point estimate for cumulative payouts through year-end 2025 is approaching ~$24B (c), an extrapolation from the documented subset and explicitly order-of-magnitude.
The analytical observation that frames this section for the whole series (c, inference): the subset's gross payout run-rate ($0.56–0.59B/yr) already exceeds the estimated systemwide net depletion ($0.5B/yr (c)). If both are roughly right, investment returns and residual funding events are offsetting a large share of gross payouts — aggregate balances decline more slowly than the pace of checks written. That is an inference from mixed-confidence inputs and should be quoted as such.
Rapid-American supplied the year's end-of-life data point: the trust stopped accepting claims, depleted, on June 6, 2025, with final payouts in the ~18–21% range (b). Its record is retained in the dataset: closure, not exhaustion-by-invisibility, is what the end of a trust looks like when it is documented. Claimant mortality acts on the system slowly and is not separately quantified in the dataset — we flag that gap rather than estimate around it.
No new asbestos §524(g) trust was funded in 2025 within the tracked system (b). The year's system-level action was in the courts and in governance.
The Fourth Circuit decided the year's two landmark §524(g) opinions. In Truck Insurance Exchange v. Kaiser Gypsum (No. 21-1858), decided April 29, 2025, the court affirmed confirmation of Kaiser Gypsum's plan on remand from the Supreme Court — holding that the trust's note-and-pledge structure satisfies §524(g)'s funding and control requirements and rejecting the insurer's bad-faith objections for want of any documented fraud evidence (a, appellate opinion). In Official Committee of Asbestos Claimants v. Bestwall (No. 24-1493), decided August 1, 2025, a divided panel held that federal courts have subject-matter jurisdiction over even a solvent debtor's Chapter 11 — keeping Georgia-Pacific's Bestwall vehicle in bankruptcy — and the full court denied rehearing en banc on October 30, 2025, by an 8–6 vote, over a dissent warning of a "manufactured sham bankruptcy" (a, appellate opinion and order). The fight over solvent-debtor asbestos bankruptcies is now a confirmation-and-good-faith fight, not a jurisdictional one — and it is not over.
Elsewhere in the formation pipeline: DBMP LLC (CertainTeed) remained in Chapter 11 in the W.D.N.C. at year-end, its stay-relief litigation on appeal with roughly 60,000 stayed lawsuits in the balance (b, docket reporting). Trane's Aldrich Pump and Murray Boiler units have been in Chapter 11 since June 2020 with no trust yet confirmed (b). None of the three carries a figure in the dataset; none should be counted until funding is documented.
Governance consolidation was 2025's defining structural trend. Effective November 14, 2025, TDP §5.5 amendments tightened eligibility for non-mesothelioma secondary-exposure claims — requiring exposure durations at least five times those of worker claims — in verbatim-identical text across the DCPF-administered trusts (a). On December 10–11, 2025, identical notices launched the Cross-Trust Audit Program: monthly random audits of approved-but-unpaid claims across all 10 DCPF trusts, using pooled claimant data (a) — the first cross-trust fraud-detection infrastructure the system has had. The direction was visible early in the year: Celotex issued a "2025 Notice to Firms re: Audit" on January 22, 2025 (a). And on December 31, 2025, NARCO paused claims intake ahead of its documented transition to DCPF administration, with resumption expected in January 2026 per trust notices (a). DCPF's 10 named trusts — Armstrong, B&W, Celotex, Federal-Mogul, Flintkote, NARCO, Owens Corning/Fibreboard, Pittsburgh Corning, USG, and W.R. Grace (b, site methodology) — account for roughly $8.7B, about 51% of the documented floor (derived from (a)/(b) figures with mixed as-of dates). When one administrator's policy change propagates to half the system's documented assets within a quarter, administrator-level governance is system-level governance. 2025 is the year that became documented fact.
| Class | Trusts | Assets carried | Share of documented floor |
|---|---|---|---|
| (a) Filed court document | ~9 | ≈$4.0B (FY2024 vintages + Manville quarterlies) | ~23% |
| (b) Secondary citing primary | 32 | $13,076,231,337 | ~77% |
| (c) Estimate/inference | 0 | excluded from point sum | — |
Upgraded this year: none — tier membership was static through 2025; the class-(a) tier stands where the FY2024 filing season left it. Verified during backfill and queued for the changes log: the Quigley October 2025 cut (a), the H.K. Porter January 2025 resumption (a), and the Celotex January 2025 audit notice (a). Staleness: all 32 class-(b) figures — 28 dated FY2022, 4 FY2021 — are beyond the site's 18-month staleness threshold, and every passing quarter widens the gap between the documented floor and current truth. Known gaps: ~19 of ~60 active trusts publish no retrievable figure; dual-rate structures (Quigley's Releasing/Non-Releasing rates) are not fully captured; four annual reports are PACER-only (W.R. Grace FY2024, Pittsburgh Corning FY2024, Celotex FY2024, B&W FY2024 — filed but not in the free RECAP archive); the Delticus/Bendix trust publishes no public financials. Aggregate-level class-(c) figures in use: the $22.5B high, the ~$24B cumulative-payout point, and the ~$0.5B/yr net-depletion rate.
Next issue: ATR-2026-Q1, expected April 2026. Corrections and sourcing disputes: open an issue on this repository. Figures marked (c) must not be cited as primary evidence.